Ethyl 2-((tert-butoxycarbonyl)amino)oxazole-5-carboxylate

Catalog No.: 
ACYQXB743
CAS No.: 
941294-50-4
Molecular Formula: 
C11H16N2O5
Molecular Weight: 
256.26
Ethyl 2-((tert-butoxycarbonyl)amino)oxazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$196.00InquiryInquiry
5g98%$723.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-((tert-butoxycarbonyl)amino)oxazole-5-carboxylate
IUPAC Nameethyl 2-((tert-butoxycarbonyl)amino)oxazole-5-carboxylate
MDL No.E188473
Molecular FormulaC11H16N2O5
Molecular Weight256.26
SMILESO=C(C1=CN=C(NC(OC(C)(C)C)=O)O1)OCC
InChI KeyKKWALHUVCIYBSO-UHFFFAOYSA-N
Synonym941294-50-4 | ETHYL 2-(T-BUTOXYCARBONYLAMINO)OXAZOLE-5-CARBOXYLATE | Ethyl 2-((tert-butoxycarbonyl)amino)oxazole-5-carboxylate | Ethyl 2-((tert-butoxycarbonyl)-amino)oxazole-5-carboxylate | ETHYL 2-(T-BOC-AMINO)OXAZOLE-5-CARBOXYLATE | ethyl 2-[(2-methylpropan-2-yl)
CAS No.941294-50-4

Synthetic Route by SureRoute

1. ACYQXB743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRPVY217 route compound structure diagram
    ACRPVY217113853-16-0In Stock
  4. Then
  5. ACYQXB743 route product structure diagram
    ACYQXB743941294-50-4
Inquiry

2. ACYQXB743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEHQO530 route compound structure diagram
    ACEHQO5304248-19-5In Stock
  2. Plus
  3. ACYIJF312 route compound structure diagram
    ACYIJF312862599-47-1In Stock
  4. Then
  5. ACYQXB743 route product structure diagram
    ACYQXB743941294-50-4
Inquiry

3. ACYQXB743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYQXB743 route product structure diagram
    ACYQXB743941294-50-4
Inquiry

Comments (0)